High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment

PHASE4CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

November 2, 2018

Study Completion Date

November 2, 2018

Conditions

Helicobacter Pylori Infection

Interventions

DRUG

Esomeprazole

Proton pump inhibitor

DRUG

Amoxicillin

Antibiotic for H. pylori eradication

DRUG

Bismuth Potassium Citrate

Gastric mucosal protective drug with anti-H. pylori effect

Trial Locations (1)

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors

lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT03405584 - High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment | Biotech Hunter | Biotech Hunter